ID   TRAMP-C2
AC   CVCL_3615
SY   TRAMP C2
DR   BTO; BTO_0005114
DR   CLO; CLO_0009402
DR   AddexBio; C0019006/5004
DR   ATCC; CRL-2731
DR   Wikidata; Q54972949
RX   PubMed=9269988;
CC   Doubling time: 25.4 hours (PubMed=9269988).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; SV40 large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_3614 ! TRAMP-C1
OI   CVCL_3616 ! TRAMP-C3
SX   Male
AG   32W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
RX   PubMed=9269988;
RA   Foster B.A., Gingrich J.R., Kwon E.D., Madias C., Greenberg N.M.;
RT   "Characterization of prostatic epithelial cell lines derived from
RT   transgenic adenocarcinoma of the mouse prostate (TRAMP) model.";
RL   Cancer Res. 57:3325-3330(1997).
//